Company Name:Cerus Corp.
CEO: William Mariner Greenman

Sector: Health Technology

Exchange: NASDAQ

Country: US

Description: Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.


Key numbers

Market Capitalization:1151195760
Shares Outstanding: 163988000
Float: 160311225
Next Earning Date:2020-08-04
TTm EPS: -0.4775
TTm Dividend Rate:
200 days moving average:5.06
50 days moving average: 6.43
One day percent Change: -0.83



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,